Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cells. (Q52629451)
Jump to navigation
Jump to search
scientific article published on 5 September 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cells. |
scientific article published on 5 September 2012 |
Statements
Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cells. (English)
Wan-Ching Yen
Marcus M Fischer
Mark Hynes
Jingjiang Wu
Edward Kim
Lucia Beviglia
V Pete Yeung
Xiaomei Song
Ann M Kapoun
John Lewicki
Austin Gurney
Diane M Simeone
Timothy Hoey
5 September 2012
18
19
5374-5386